Merck & Co. (MRK)
(Delayed Data from NYSE)
$117.17 USD
-0.06 (-0.05%)
Updated Sep 20, 2024 04:01 PM ET
After-Market: $117.31 +0.14 (0.12%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth D Momentum C VGM
Brokerage Reports
Merck & Co., Inc. [MRK]
Reports for Purchase
Showing records 1 - 20 ( 403 total )
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 091624
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Key Takeaways from KOL Panels at Our Immune Cell Engager Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for MRK 21224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department